Most bought healthcare stocks in Q1 2015

See which Healthcare stocks institutional investors increased the most in Q1 2015, measured as net growth in reported share positions from Q4 2014 into Q1 2015. Notable additions at the top of this list include ILLUMINA INC (ILMN), TEVA PHARMACEUTICAL-SP ADR (TEVA), GILEAD SCIENCES INC (GILD), BAXTER INTERNATIONAL INC (BAX). These rankings aggregate SEC 13F filings from all institutional investors in our database.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
ILMNILLUMINA INC2,752,794$520.32K11104
TEVATEVA PHARMACEUTICAL-SP ADR2,364,785$166.26K14005
GILDGILEAD SCIENCES INC2,183,180-$10.01M077014
BAXBAXTER INTERNATIONAL INC2,004,859$87.78K13309
DVADAVITA INC1,903,108-$297.69M02206
PFEPFIZER INC1,711,665$12.88M118112
DHRDANAHER CORP1,513,443$114.32K11205
ZTSZOETIS INC1,425,793$206.77K02004
OPKOPKO HEALTH INC1,253,398$17.76K10001
VRTXVERTEX PHARMACEUTICALS INC1,165,267$136.83K11002
LLYELI LILLY & CO901,082$101.17K10405
RHHBYROCHE HOLDINGS LTD-SPONS ADR874,505$31.17K02002
AZNASTRAZENECA PLC-SPONS ADR866,500$54.80K01002
AMRNAMARIN CORP PLC -ADR732,490$1.71K10001
GERNGERON CORP605,265$3.09K01102
MOHMOLINA HEALTHCARE INC527,200$37.99K01001
CVSCVS HEALTH CORP433,839-$11.75M11618
VEEVVEEVA SYSTEMS INC-CLASS A414,100$10.47K01002
CNCCENTENE CORP393,900$23.81K01001
OSURORASURE TECHNOLOGIES INC392,997$85301001
AMNAMN HEALTHCARE SERVICES INC363,800$8.60K01001
AAGILENT TECHNOLOGIES INC339,138$16.84K01103
AMGNAMGEN INC316,678$16.69M11407
UTHRUNITED THERAPEUTICS CORP273,662$70.61K02002
ENZENZO BIOCHEM INC269,306-$61301001
WATWATERS CORP253,650$62.80K12104
OMIOWENS & MINOR INC251,310$7.25K02002
CARACARA THERAPEUTICS INC248,882$2.50K01001
SRPTSAREPTA THERAPEUTICS INC232,261$2.89K01001
BRKRBRUKER CORP226,310$4.18K10001
BMYBRISTOL-MYERS SQUIBB CO203,482$173.51K22319
VNDAVANDA PHARMACEUTICALS INC195,100$1.81K10001
REGNREGENERON PHARMACEUTICALS192,060$109.07K11002
MMSIMERIT MEDICAL SYSTEMS INC190,714$3.82K01001
RGENREPLIGEN CORP165,861$12.37K01001
ISRGINTUITIVE SURGICAL INC152,210$70.86K01103
HALOHALOZYME THERAPEUTICS INC146,670$20.93K01102
CDXSCODEXIS INC145,000$1.31K01001
INGNINOGEN INC142,900$4.58K01001
CRLCHARLES RIVER LABORATORIES139,113$49.35K01112
ESPRESPERION THERAPEUTICS INC136,919$12.68K10001
CERSCERUS CORP136,000$56710001
NKTRNEKTAR THERAPEUTICS135,900-$44901001
AMPHAMPHASTAR PHARMACEUTICALS IN123,380$1.85K10001
STXSSTEREOTAXIS INC121,600$27001001
BIOBIO-RAD LABORATORIES-A115,575$32.33K02002
NEONEOGENOMICS INC107,700$57101001
JNJJOHNSON & JOHNSON106,467-$12.15M0610019
MDPEDIATRIX MEDICAL GROUP INC103,792$9.81K01011
MGNXMACROGENICS INC103,576$1.93K02002
Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.0.00757.0K1.5M2.3M3.0MNet change in reported shares (all institutional filers)ILMNTEVAGILDBAXDVAPFEDHRZTSOPKVRTXLLYRHHBYAZNAMRNGERNMOHCVSVEEVCNCOSURSymbol

Frequently asked questions about Most bought healthcare stocks in Q1 2015

  • What are the most bought Healthcare stocks in Q1 2015?

    The most bought healthcare stocks in Q1 2015 are those with the largest increase in reported share counts across institutional investors compared to Q4 2014, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q1 2015?

    Among filers in this sector, net additions were largest in companies such as ILLUMINA INC (ILMN), TEVA PHARMACEUTICAL-SP ADR (TEVA), GILEAD SCIENCES INC (GILD), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2014).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.